Felis consequat magnis est fames sagittis ultrices placerat sodales porttitor quisque.
In barely a decade, China has transformed from a maker of cheap generic copies of Western medicines into a global powerhouse of pharmaceutical innovation.
The country now only trails the United States in novel drugs under development, with a 29 per cent share, according to McKinsey. International pharmaceutical companies are beating a path to China’s shores to license next-generation treatments for cancer, autoimmune diseases and other disorders.
Government support, including regulatory and…
Media365Amid geopolitical tensions, China’s Tianqi Lithium has decided to skip Africa and will stick to domestic salt lakes to secure the supply of a battery mineral, according to its president…
Media365Hong Kong developers released nearly 300 new flats to the market amid enthusiastic demand from potential homebuyers as the latest official data show completion of private residential units is set…
